Restatement of Previously Issued Financial Statements - Schedule of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (60,808)	$ (81,393)	$ (69,804)	$ (87,232)	$ (62,789)	$ 18,930	$ (212,003)	$ (131,091)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization							47,339	19,660
Stock-based compensation expense							9,669	16,013
Noncash research and development expense (finance lease)							0	22,223
Noncash operating lease expense							18,015	23,965
Gain from sale of priority review voucher	0			0			0	(92,930)
Change in excess inventory reserve							8,035	9,202
Other non-cash items							(14)	100
Gain on foreign currency exchange rates							(86)	(1,062)
Changes in operating assets and liabilities:
Accounts receivable							0	(14,600)
Prepaid expenses and other assets							(47,022)	2,117
Inventory							(38,038)	(26,197)
Operating right of use assets								0
Accounts payable							6,660	1,712
Accrued expenses and other liabilities							2,986	5,709
Accrued interest payable under finance lease							(8,010)	(3,203)
Operating lease liabilities							15,323	18,686
Deferred revenue							0	(248)
Net cash (used in) provided by operating activities							(209,856)	(180,910)
Cash flows from investing activities:
Purchase of property, plant and equipment							(2,114)	(2,975)
Proceeds from maturities of marketable securities							0	(43,297)
Proceeds from maturities of marketable securities							0	99,521
Proceeds from sales of marketable securities							0	5,853
Purchase of intangible assets							0	(868)
Proceeds from sale of priority review voucher							0	92,930
Net cash provided by investing activities							1,432	151,164
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions							0	93
Principal payments on finance leases							(69,576)	(40,299)
Net cash provided by financing activities							52,479	89,670
Increase in cash, cash equivalents and restricted cash							(155,945)	59,924
Cash, cash equivalents and restricted cash at beginning of period			$ 274,597			158,445	274,597	158,445
Cash, cash equivalents and restricted cash at end of period	118,652			218,369			118,652	218,369
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	70,651			165,347			70,651	165,347	$ 221,755
Restricted cash included in other current assets	4,360			8,885			4,360	8,885
Restricted cash included in restricted cash and other non-current assets	43,641			44,137			43,641	44,137
Total cash, cash equivalents and restricted cash	$ 118,652			218,369			118,652	218,369	$ 274,597
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities							0	(708)
Purchases of property, plant and equipment included in accounts payable and accrued expenses							31	941
Offering expenses included in accounts payable and accrued expenses							0	248
Right-of-use assets obtained in exchange for finance lease liabilities							41,893	21,508
Increase (reduction) of right of use asset and associated operating lease liability due to lease reassessment								0
Cash paid during the period for income taxes								5
As Previously Reported
Cash flows from operating activities:
Net loss				(71,731)	(72,908)	21,240		(123,399)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization								3,124
Stock-based compensation expense								16,013
Noncash research and development expense (finance lease)								0
Noncash operating lease expense								0
Gain from sale of priority review voucher								(92,930)
Change in excess inventory reserve								5,333
Other non-cash items								19
Gain on foreign currency exchange rates								0
Changes in operating assets and liabilities:
Accounts receivable								(23,000)
Prepaid expenses and other assets								(523)
Inventory								(24,931)
Operating right of use assets								(40,101)
Accounts payable								(5,787)
Accrued expenses and other liabilities								7,125
Accrued interest payable under finance lease								0
Operating lease liabilities								30,506
Deferred revenue								8,152
Net cash (used in) provided by operating activities								(221,209)
Cash flows from investing activities:
Purchase of property, plant and equipment								(2,975)
Proceeds from maturities of marketable securities								(43,297)
Proceeds from maturities of marketable securities								99,521
Proceeds from sales of marketable securities								5,853
Purchase of intangible assets								(868)
Proceeds from sale of priority review voucher								92,930
Net cash provided by investing activities								151,164
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions								93
Principal payments on finance leases								0
Net cash provided by financing activities								129,969
Increase in cash, cash equivalents and restricted cash								59,924
Cash, cash equivalents and restricted cash at beginning of period						158,445		158,445
Cash, cash equivalents and restricted cash at end of period				218,369				218,369
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents				165,347				165,347
Restricted cash included in other current assets				8,885				8,885
Restricted cash included in restricted cash and other non-current assets				44,137				44,137
Total cash, cash equivalents and restricted cash				218,369				218,369
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities								44,819
Purchases of property, plant and equipment included in accounts payable and accrued expenses								941
Offering expenses included in accounts payable and accrued expenses								248
Right-of-use assets obtained in exchange for finance lease liabilities								0
Increase (reduction) of right of use asset and associated operating lease liability due to lease reassessment								8,003
Cash paid during the period for income taxes								5
Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from operating activities:
Net loss				(17,139)	9,482	(2,351)		(10,008)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization								16,648
Stock-based compensation expense								0
Noncash research and development expense (finance lease)								22,223
Noncash operating lease expense								23,965
Gain from sale of priority review voucher								0
Change in excess inventory reserve								1,554
Other non-cash items								0
Gain on foreign currency exchange rates								(1,062)
Changes in operating assets and liabilities:
Accounts receivable								0
Prepaid expenses and other assets								2,640
Inventory								1,651
Operating right of use assets								40,101
Accounts payable								7,183
Accrued expenses and other liabilities								583
Accrued interest payable under finance lease								(3,203)
Operating lease liabilities								(11,820)
Deferred revenue								0
Net cash (used in) provided by operating activities								40,299
Cash flows from investing activities:
Purchase of property, plant and equipment								0
Proceeds from maturities of marketable securities								0
Proceeds from maturities of marketable securities								0
Proceeds from sales of marketable securities								0
Purchase of intangible assets								0
Proceeds from sale of priority review voucher								0
Net cash provided by investing activities								0
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions								0
Principal payments on finance leases								(40,299)
Net cash provided by financing activities								(40,299)
Increase in cash, cash equivalents and restricted cash								0
Cash, cash equivalents and restricted cash at beginning of period						0		0
Cash, cash equivalents and restricted cash at end of period				0				0
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents				0				0
Restricted cash included in other current assets				0				0
Restricted cash included in restricted cash and other non-current assets				0				0
Total cash, cash equivalents and restricted cash				0				0
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities								(45,527)
Purchases of property, plant and equipment included in accounts payable and accrued expenses								0
Offering expenses included in accounts payable and accrued expenses								0
Right-of-use assets obtained in exchange for finance lease liabilities								21,508
Increase (reduction) of right of use asset and associated operating lease liability due to lease reassessment								(8,003)
Cash paid during the period for income taxes								0
Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from operating activities:
Net loss				1,638	$ 637	41		2,316
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization								(112)
Stock-based compensation expense								0
Noncash research and development expense (finance lease)								0
Noncash operating lease expense								0
Gain from sale of priority review voucher								0
Change in excess inventory reserve								2,315
Other non-cash items								81
Gain on foreign currency exchange rates								0
Changes in operating assets and liabilities:
Accounts receivable								8,400
Prepaid expenses and other assets								0
Inventory								(2,917)
Operating right of use assets								0
Accounts payable								316
Accrued expenses and other liabilities								(1,999)
Accrued interest payable under finance lease								0
Operating lease liabilities								0
Deferred revenue								(8,400)
Net cash (used in) provided by operating activities								0
Cash flows from investing activities:
Purchase of property, plant and equipment								0
Proceeds from maturities of marketable securities								0
Proceeds from maturities of marketable securities								0
Proceeds from sales of marketable securities								0
Purchase of intangible assets								0
Proceeds from sale of priority review voucher								0
Net cash provided by investing activities								0
Cash flows from financing activities:
Proceeds from exercise of stock options and ESPP contributions								0
Principal payments on finance leases								0
Net cash provided by financing activities								0
Increase in cash, cash equivalents and restricted cash								0
Cash, cash equivalents and restricted cash at beginning of period						$ 0		0
Cash, cash equivalents and restricted cash at end of period				0				0
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents				0				0
Restricted cash included in other current assets				0				0
Restricted cash included in restricted cash and other non-current assets				0				0
Total cash, cash equivalents and restricted cash				$ 0				0
Supplemental cash flow disclosures from investing and financing activities:
Right-of-use assets obtained in exchange for operating lease liabilities								0
Purchases of property, plant and equipment included in accounts payable and accrued expenses								0
Offering expenses included in accounts payable and accrued expenses								0
Right-of-use assets obtained in exchange for finance lease liabilities								0
Increase (reduction) of right of use asset and associated operating lease liability due to lease reassessment								0
Cash paid during the period for income taxes								0
Private Placement
Cash flows from financing activities:
Proceeds from issuance of common stock							0	(196)
Private Placement | As Previously Reported
Cash flows from financing activities:
Proceeds from issuance of common stock								(196)
Private Placement | Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from financing activities:
Proceeds from issuance of common stock								0
Private Placement | Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from financing activities:
Proceeds from issuance of common stock								0
Public Offering
Cash flows from financing activities:
Proceeds from issuance of common stock							$ 0	130,072
Public Offering | As Previously Reported
Cash flows from financing activities:
Proceeds from issuance of common stock								130,072
Public Offering | Revision of Prior Period, Error Correction, Adjustment | Adjustments to Embedded Leases
Cash flows from financing activities:
Proceeds from issuance of common stock								0
Public Offering | Revision of Prior Period, Error Correction, Adjustment | Other Adjustments
Cash flows from financing activities:
Proceeds from issuance of common stock								$ 0